---
title: "Goldman Sachs Keeps Their Sell Rating on DBV Technologies SA – American (DBVT)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282393496.md"
description: "Goldman Sachs analyst Rajan Sharma has maintained a Sell rating on DBV Technologies SA – American (DBVT) with a price target of $5.81. Despite this, the analyst consensus for DBVT is a Moderate Buy, with a higher price target consensus of $39.64. Sharma, who focuses on the Healthcare sector, has an average return of 0.7% and a 50.53% success rate on his stock recommendations."
datetime: "2026-04-10T18:45:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282393496.md)
  - [en](https://longbridge.com/en/news/282393496.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282393496.md)
---

# Goldman Sachs Keeps Their Sell Rating on DBV Technologies SA – American (DBVT)

In a report released yesterday, Rajan Sharma from Goldman Sachs maintained a Sell rating on DBV Technologies SA – American, with a price target of $5.81.

### Easter Sale - 70% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Sharma covers the Healthcare sector, focusing on stocks such as AstraZeneca, Immunocore Holdings, and Valneva. According to TipRanks, Sharma has an average return of 0.7% and a 50.53% success rate on recommended stocks.

DBV Technologies SA – American has an analyst consensus of Moderate Buy, with a price target consensus of $39.64.

### Related Stocks

- [DBVT.US](https://longbridge.com/en/quote/DBVT.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Does DBV Technologies' (ENXTPA:DBV) ESOP-Linked Share Shelf Highlight a Deeper Funding Strategy Shift?](https://longbridge.com/en/news/285920931.md)
- [LifeSci Capital Sticks to Their Buy Rating for MoonLake Immunotherapeutics (MLTX)](https://longbridge.com/en/news/286649191.md)
- [UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP](https://longbridge.com/en/news/286878927.md)
- [ELFI offers new private student loan alternative for medical and healthcare students facing federal loan changes](https://longbridge.com/en/news/286929682.md)
- [Damora Therapeutics (DMRA) Receives a Rating Update from a Top Analyst](https://longbridge.com/en/news/286678740.md)